ALK, a receptor tyrosine kinase, was originally identified in lung cancer in 2007 with the detection of an echinoderm microtubule-associated protein-like 4 (EML4) gene and anaplastic lymphoma kinase (ALK) gene fusion from a surgically resected lung adenocarcinoma patient [70]. The gene discussed is ALK; the disease is lung carcinoma.